Avid Bioservices Inc (CDMO)

[biopharm]

Thanks golfho and maybe one day ..we hear more

____

Andrew F Dorr -

April 21, 2017

F. Andrew Dorr, M.D., the Company’s previous interim chief medical officer, will transition his work to focus on the clinical development of the Company’s oncology programs.

https://seekingalpha.com/filing/3510273

______

Andrew F Dorr, who was not on research published reports of Peregrine re: biomarkers ...but does show up with Joe Shan, Steve King and Nikoletta Kallinteris with patent date filing below...dated

(Page 8 of 12 ...verified that MOS not met yet )

(54) METHODS FOR TREATING CANCER USING PS-TARGETING ANTIBODIES WITH IMMUNO -ONCOLOGY AGENTS

(71) Aplicant:
ONCOLOGIE,INC.,
WestNewton, MA (US)

(72) Inventors:

JosephS.Shan,Tustin,CA(US); NikoletaL.Kalinteris,Tustin,CA(US);
Min Tang,Tustin,CA (US);
F. Andrew Dorr,Tustin,CA (US)

(21) Apl.No.:15/943,304

(2)Filed: Apr.2,2018

https://patentimages.storage.googleapis.com/b4/e9/50/d138e8f8a7a2b2/US20180289771A1.pdf

________


Who knows, maybe S-Bio wants IP asset knowledge


S*BIO Pte Ltd

S*BIO Pte Ltd., a biotech company, focuses on the discovery, research, and clinical development of small molecule drugs.
Singapore, Central Region, Singapore

Categories
Biotechnology, Genetics, Life Science

Headquarters Regions
Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia

Sub-Organization of
Logo of Chiron Corporation
Chiron Corporation

Founded Date
2000

Operating Status
Active

IPO Status
Private

S*Bio Pte Ltd. (Singapore), The principle activity of the company is the discovery and development of novel, proprietary small molecule anti-cancer drugs. This is done through an in-house discovery team located in Singapore and a clinical development team located in Singapore and Calfornia.


https://www.crunchbase.com/organization/s-bio-pte-ltd

_____

I wonder why Lana Gladstein was hired by Mark Bamforth new CDMO Arranta...maybe she advised Jeffrey Gladstein ( Merrill Lynch Wells Fargo) to buy big CDMO and maybe Christopher Sargent also of Merrill Lynch Wells Fargo buys big CDMO (Chris had to leave Wells Fargo for a reason and split off ....and started the buying already for some

As for Andrew F Dorr....he holds key Biomarker info and knows PS Targeting is huge ..so I wonder why James Allison and crew over at "Imaginab" required PS Targeting input from Andrew F Dorr ...as they seeked him out AFTER the patent and Biomarkers etc

Merck or another....should just open the vault